Home › Essential Thrombocythemia › Illinois › Chicago
Essential Thrombocythemia clinical trials in Chicago, IL
4 studies for Essential Thrombocythemia are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
RecruitingPhase 3
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
- University of Chicago, Chicago
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RecruitingPhase 2
- University of Chicago Comprehensive Cancer Center, Chicago
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- University of Chicago Medical Center, Chicago
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
RecruitingObservational study
- MPN Research Foundation, Chicago
Essential Thrombocythemia trials in other cities
- New York City, NY8 studies
- Durham, NC7 studies
- Nashville, TN5 studies
- Salt Lake City, UT5 studies
- Boston, MA5 studies
- Baltimore, MD5 studies
- Mountain View, CA4 studies
- Irvine, CA4 studies
- Columbus, OH4 studies
- Miami, FL4 studies
- Houston, TX4 studies
- St. Louis, MO4 studies
Other studies in Chicago
- Breast Cancer59 studies
- Non-Small Cell Lung Cancer59 studies
- Cancer (all types)51 studies
- Prostate Cancer45 studies
- Lung Cancer43 studies
- Metastatic Cancer42 studies
- Obesity40 studies
- Ovarian Cancer36 studies
- Colorectal Cancer32 studies
- Stroke31 studies
- Head and Neck Squamous Cell Carcinoma29 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.